The quality of life assessment after radical prostatectomy with usage of MEB questionnaire 13.1

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The quality of life assessment for 180 patients with prostate cancer after radical prostatectomy was carried out. For this purpose we used the original MEB questionnaire 13.1 which included 65 questions divided in to the several blocks: urination, erectile dysfunction, pane, general quality of life assessment and the others. The performed analysis showed to the internal inquirer’s questions coordination, the correspondence between the received during the questionnaire usage results and the results after standard questionnaire usage (PC-QoL, IPSS, IIEF, OAB-q) as well as statement simplicity for the patients.

全文:

受限制的访问

作者简介

Salman Al-Shukri

First St.-Petersburg State I. P. Pavlov Medical University

Email: al-shukri@mail.ru
doctor of medical science, professor, head of the department. Department of Urology.

Yevgeniy Nevirovich

First St.-Petersburg State I. P. Pavlov Medical University

candidate of medical science, head of Urological Unit

Adel Al-Shukri

First St.-Petersburg State I. P. Pavlov Medical University

doctor of medical science, professor, Urology Department

Anton Boriskin

First St.-Petersburg State I. P. Pavlov Medical University

Email: flounder@yandex.ru
candidate of medical science, assistant professor, Urology Department

Yuliya Tyurina

First St.-Petersburg State I. P. Pavlov Medical University

student

参考

  1. Hoffman R. M. Clinical Practice. Screening for Prostate Cancer // New Engl. J. Med. 2011. Vol. 365, N 21. P. 2013–2019.
  2. Lu-Yao G. L., Albertsen P. C., Moore D. F. et al. Outcomes of localized prostate cancer following conservative management // JAMA. 2009. Vol. 302, N 11. P. 1202–1209.
  3. Greene K. L., Albertsen P. C., Babaian R. J. et al. Prostate specific antigen best practice statement: 2009 update // J. Urol. 2009. Vol. 182, N 5. P. 2232–2241.
  4. Phillips C. Study questions benefit of surgery in some men with early-stage prostate cancer // NCI cancer bulletin. 2011. Vol. 8, N 11.
  5. Roobol M. J., Kerkhof M., Schroeder F. H. et al. Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) //EurUrol. 2009. Vol. 56, N 4. P. 584–591.
  6. Thompson J. M.Jr., Goodman P. J., Tangen C. M. et al. Long-Term Survival of Participants in the Prostate Cancer Prevention Trial //New Engl. J. Med. 2013. Vol. 369, N 7. P. 603–610.
  7. Schroeder F. H., Hugosson J., Roobol M. J. et al. Prostate-Cancer Mortality at 11 Years of Follow-up // New Engl. J. Med. 2012. Vol. 366, N 11. P. 981–990.
  8. Bill-Axelson A., Holmberg L., Ruutu M. et al. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer // New Engl. J. Med. 2011. Vol. 364, N 18. P 1708–1717.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Al-Shukri S.H., Nevirovich Y.S., Al-Shukri A.S., Boriskin A.G., Tyurina Y.V., 2013

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 89281 от 21.04.2025.